Equities Analysts Issue Forecasts for Can-Fite BioPharma Ltd.’s FY2023 Earnings (NYSE:CANF)

Can-Fite BioPharma Ltd. (NYSE:CANF – Free Report) – HC Wainwright lifted their FY2023 earnings estimates for Can-Fite BioPharma in a research note issued on Wednesday, February 7th. HC Wainwright analyst V. Bernardino now expects that the company will earn ($1.85) per share for the year, up from their previous forecast of ($1.92). HC Wainwright has […]

Leave a Reply

Your email address will not be published.

Previous post Brokerages Set Annexon, Inc. (NASDAQ:ANNX) PT at $13.14
Next post Waters Co. (NYSE:WAT) to Post Q1 2024 Earnings of $2.08 Per Share, Leerink Partnrs Forecasts